Sarepta Therapeutics to Announce Third Quarter 2026 Financial Results
Business Wire•22/10/2026•08:30 ET
0
Key Highlights
- ➤Sarepta will report third-quarter 2026 financial results after market close November 5, 2026
- ➤Conference call scheduled for 4:30 p.m. ET following results release
- ➤Sarepta maintains a Duchenne muscular dystrophy leadership position and rare-disease pipeline
Sarepta Therapeutics to Announce Third Quarter 2026 Financial Results
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2026 financial results after the Nasdaq Global Market closes on Thursday, Nov. 5, 2026. Subsequently, at 4:30 p.m. ET, the Company will host a conference call to discuss these results.
Get started
Create a free account to read the full story.